Safety and efficacy of dual lumen balloon catheters for the Treatment of cerebral vascular malformations: A systematic review, pooled analysis, and meta-analysis.
Dual-lumen balloon catheters
arteriovenous malformation
dural arteriovenous fistula
embolization
occlusion outcome
single-lumen catheters
treatment times
Journal
The neuroradiology journal
ISSN: 2385-1996
Titre abrégé: Neuroradiol J
Pays: United States
ID NLM: 101295103
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
pmc-release:
01
08
2024
medline:
19
7
2023
pubmed:
24
6
2022
entrez:
23
6
2022
Statut:
ppublish
Résumé
There is little evidence in scientific literature assessing the safety and efficacy of dual-lumen balloon catheters (DLBCs) and their performance compared to single-lumen catheters (SLCs). In this PROSPERO-registered, PRISMA-compliant systematic review, we identified all MEDLINE and EMBASE single-arm (DLBCs) and double-arm (DLBCs vs SLCs) cohorts where DLBCs were used for the treatment of cerebral arteriovenous malformations (AVMs) or dural arteriovenous fistulas (dAVFs). Immediate angiographic outcome, vascular complications, technical failures, reflux episodes and entrapment were the primary outcomes. A meta-analysis of the double-arm studies summarized the primary outcomes of total procedural time and immediate angiographic outcome. The authors identified 18 studies encompassing 209 treated lesions with reported outcomes. Complete occlusion was achieved in 108/132 treated dAVFs (81.8%, 95% CI: [74-87.8%]) and in 45/77 treated AVMs (58.4%, [46.7-69.4%]). The proportion of completely occluded dAVFs was statistically significantly higher than that of AVMs, Dual-lumen balloon catheters are safe and effective for the embolization of cerebral AVMs and dAVFs and can achieve faster and potentially superior results compared to SLCs. https://www.crd.york.ac.uk/prospero/ Unique Identifier: CRD42021269096.
Sections du résumé
BACKGROUND
BACKGROUND
There is little evidence in scientific literature assessing the safety and efficacy of dual-lumen balloon catheters (DLBCs) and their performance compared to single-lumen catheters (SLCs).
METHODS
METHODS
In this PROSPERO-registered, PRISMA-compliant systematic review, we identified all MEDLINE and EMBASE single-arm (DLBCs) and double-arm (DLBCs vs SLCs) cohorts where DLBCs were used for the treatment of cerebral arteriovenous malformations (AVMs) or dural arteriovenous fistulas (dAVFs). Immediate angiographic outcome, vascular complications, technical failures, reflux episodes and entrapment were the primary outcomes. A meta-analysis of the double-arm studies summarized the primary outcomes of total procedural time and immediate angiographic outcome.
RESULTS
RESULTS
The authors identified 18 studies encompassing 209 treated lesions with reported outcomes. Complete occlusion was achieved in 108/132 treated dAVFs (81.8%, 95% CI: [74-87.8%]) and in 45/77 treated AVMs (58.4%, [46.7-69.4%]). The proportion of completely occluded dAVFs was statistically significantly higher than that of AVMs,
CONCLUSION
CONCLUSIONS
Dual-lumen balloon catheters are safe and effective for the embolization of cerebral AVMs and dAVFs and can achieve faster and potentially superior results compared to SLCs.
REGISTRATION-URL
UNASSIGNED
https://www.crd.york.ac.uk/prospero/ Unique Identifier: CRD42021269096.
Identifiants
pubmed: 35738884
doi: 10.1177/19714009221111089
pmc: PMC10588609
doi:
Substances chimiques
Polyvinyls
0
Types de publication
Systematic Review
Meta-Analysis
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
379-387Références
Neurosurgery. 2013 Dec;73(2 Suppl Operative):ons238-43; discussion ons243
pubmed: 24077579
J Neurointerv Surg. 2015 Jun;7(6):458-61
pubmed: 24714611
Acta Neurochir (Wien). 2016 Oct;158(10):1917-23
pubmed: 27522356
J Clin Neurosci. 2020 Nov;81:295-301
pubmed: 33222933
Neuroradiol J. 2021 Dec;34(6):562-567
pubmed: 34014796
Clin Neuroradiol. 2020 Jun;30(2):313-319
pubmed: 30972426
Neuroradiol J. 2022 Aug;35(4):520-526
pubmed: 34609932
Interv Neurol. 2018 Oct;7(6):439-444
pubmed: 30410522
J Neurosurg. 2010 Oct;113(4):733-41
pubmed: 20433277
Interv Neuroradiol. 2021 Apr;27(2):298-306
pubmed: 33164616
CVIR Endovasc. 2019 Jun 29;2(1):20
pubmed: 32026996
J Neurosurg. 2011 Jul;115(1):78-88
pubmed: 21476804
Neurosurgery. 2014 Feb;74 Suppl 1:S74-82
pubmed: 24402496
AJNR Am J Neuroradiol. 2009 Jan;30(1):99-106
pubmed: 18842759
J Neurointerv Surg. 2013 Jul;5(4):e18
pubmed: 22730338
AJNR Am J Neuroradiol. 2017 Oct;38(10):1984-1989
pubmed: 28818827
J Neurointerv Surg. 2020 Nov;12(11):1132-1136
pubmed: 32434799
JAMA. 2011 Nov 9;306(18):2011-9
pubmed: 22068993
Interv Neuroradiol. 2021 Oct;27(5):663-666
pubmed: 33611967
J Neurointerv Surg. 2021 Mar;13(3):261-266
pubmed: 32546639
J Neurointerv Surg. 2014 Jun;6(5):400-3
pubmed: 23749795
World Neurosurg. 2020 Sep;141:383-388
pubmed: 32592963
Eur Radiol. 2013 Oct;23(10):2838-45
pubmed: 23652849
AJNR Am J Neuroradiol. 2010 May;31(5):947-54
pubmed: 20190210
J Cerebrovasc Endovasc Neurosurg. 2017 Sep;19(3):223-230
pubmed: 29159158
J Neurointerv Surg. 2015 Oct;7(10):721-7
pubmed: 25118193
J Neuroradiol. 2013 Oct;40(4):294-302
pubmed: 24074560
J Neurointerv Surg. 2015 Oct;7(10):740-3
pubmed: 25165384
J Clin Epidemiol. 2021 Jun;134:178-189
pubmed: 33789819
World Neurosurg. 2016 Dec;96:370-374
pubmed: 27633716
Clin Neurol Neurosurg. 2014 Feb;117:22-27
pubmed: 24438799
BMC Neurol. 2021 Jan 20;21(1):31
pubmed: 33472604
J Neurointerv Surg. 2023 Jan;15(1):97-98
pubmed: 35428741
Neurosurgery. 2016 May;78(5):627-36
pubmed: 26488328
Stroke. 2017 Aug;48(8):e200-e224
pubmed: 28642352